The above results have confirmed that silencing of ENO1 could get similar results to treating BLCA cells with melatonin, so we hope to further explore the role of ENO1 in the inhibitory effect of melatonin on BLCA cells. The gene discussed is ENO1; the disease is bladder transitional cell carcinoma.